GENFF (Genflow Biosciences) Total Payout Yield % : 0.00 (As of Dec. 13, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Genflow Biosciences Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Genflow Biosciences's current Total Payout Yield % is 0.00%.

Genflow Biosciences Total Payout Yield % Historical Data

The historical data trend for Genflow Biosciences's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Total Payout Yield % Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Total Payout Yield %

Genflow Biosciences Quarterly Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Payout Yield %	Get a 7-Day Free Trial			-	-	-	-	-46.89

Competitive Comparison of Genflow Biosciences's Total Payout Yield %

For the Biotechnology subindustry, Genflow Biosciences's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's Total Payout Yield % falls into.

Genflow Biosciences Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Genflow Biosciences's Total Payout Yield % for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Market Cap
	=	- (0	+	0	+	0)	/	7.020168
	=	0.00%

Genflow Biosciences's annualized Total Payout Yield % for the quarter that ended in Jun. 2024 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0.91	+	0)	*	4	/	7.7634954
	=	-46.89%

Genflow Biosciences Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

Genflow Biosciences Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » Total Payout Yield %

Comparable Companies

Traded in Other Exchanges

GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.